| Code | Description | Claims | Beneficiaries | Total Paid |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
161 |
157 |
$82K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,643 |
1,448 |
$75K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,352 |
1,199 |
$25K |
| 97597 |
|
264 |
95 |
$23K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
461 |
379 |
$23K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
213 |
51 |
$13K |
| 99070 |
|
2,598 |
811 |
$4K |
| 80053 |
Comprehensive metabolic panel |
319 |
259 |
$2K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
102 |
76 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
527 |
408 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
91 |
47 |
$2K |
| 87077 |
|
50 |
38 |
$536.30 |
| 71046 |
Radiologic examination, chest; 2 views |
40 |
33 |
$455.27 |
| 87186 |
|
31 |
24 |
$444.79 |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
16 |
12 |
$382.32 |
| 87070 |
|
86 |
70 |
$310.85 |
| 81000 |
|
37 |
33 |
$102.34 |
| 87205 |
|
68 |
57 |
$81.11 |
| 87075 |
|
36 |
29 |
$50.16 |
| 36415 |
Collection of venous blood by venipuncture |
960 |
764 |
$45.13 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
37 |
35 |
$0.00 |